PODD

NASDAQ Healthcare

Insulet Corporation - Common Stock

Medical Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

�� 市场数据

价格	$203.73
成交量	839,021
市值	14.34B
贝塔系数	1.470
RSI（14日）	41.3
200日均线	$287.58
50日均线	$228.27
52周最高	$354.88
52周最低	$194.61
市盈率	57.88
Forward P/E	25.21
Price / Book	9.46